Target intelligence / Profile preview

Gamma-globin gene promoter region

Molecular classification
Other (Promoter region; not a protein, enzyme, receptor, or typical drug target)
01

Overview

The gamma-globin gene promoter region is a DNA sequence located upstream of the gamma-globin genes (HBG1 and HBG2), which are part of the human beta-globin locus. This promoter contains several regulatory elements—including CCAAT boxes, CACCC boxes, and GATA binding sites—that control transcription during development. The activity of this promoter is essential for proper expression during fetal life when gamma-globin chains are incorporated into fetal hemoglobin. Interactions between this promoter and distant enhancers such as the locus control region (LCR) are critical for high-level expression; specific motifs like CCAAT boxes are required for these interactions[1]. Mutations in this region can lead to hereditary persistence of fetal hemoglobin by altering regulatory element function[1]. The gamma-globin gene promoter is not itself a therapeutic target like a receptor or enzyme but is an important focus in research aimed at reactivating fetal hemoglobin production to treat diseases such as sickle cell disease and beta-thalassemia[5]. Note: This entry refers to a promoter DNA sequence, not a protein or classical druggable target. It does not fit standard molecular classification schemes used for receptors, enzymes, etc., nor does it have interacting drugs or mechanisms typical for pharmacological targets. Thus, "is_target" should be set to false and "is_incorrect" set to true if only proteins/enzymes/receptors should be included as targets.

Other names
γ-globin gene promoterHBG1/HBG2 promoter (refers to the promoters of the gamma-globin genes HBG1 and HBG2)
02

Biological functions

Regulation of gene expressionControl of developmental hemoglobin switchingInteraction with enhancer elements for transcriptional activation[1][5]
03

Disease associations

Hereditary persistence of fetal hemoglobin (HPFH)[1]Hemoglobinopathies such as sickle cell disease and beta-thalassemia (via modulation of fetal hemoglobin levels)[5]

Beyond the preview

Go deeper on Gamma-globin gene promoter region.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-globin gene promoter region.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call